|

Devoted to transforming medicine
Create a healthy tomorrow

Devoted to transforming medicine
Create a healthy tomorrow

Devoted to transforming medicine
Create a healthy tomorrow

About Genechem

Founded in 2002, Shanghai Genechem Co., Ltd. is now the leader of scientific research of China, holding more than 50% domestic market share. Over 2000 contracts are on our product platform and over 100 lentivirus packing services are ongoing everyday. We help our customers accelerate their biological or medical research by providing them with high quality gene handling tools like lentivirus, AAV, etc. We also coordinate with our customers to increase laboratory productivity. Our mission is to intensify the link between clinic and academy, making a better and healthier world.

Product

Genechem developed R&D Self-inactivation lentiviral packaging system of second generation, manufacturing self-inactivation (SIN) virus, which neither has the ability to infect other cells nor generate novel viral particles using host cell mechanism, meeting a better safety standard. The virulent part of the lentiviral particles has already been replaced with exogenous gene, leaving only the pseudovirus with low immunogenicity.

Product

Most lentiviral products on market are purified using the technology of single-round dead-end filtration, which is easy handling. However as a result, the final lentiviral product will contain DNA and serum protein which could lead to cell death and immunoreaction. Referring to the standard of DFA and <<Chinese Pharmacopoeia>> for vaccine production, Genechem developed a more strict and advanced viral purification technology based on ultrafiltration, ultracentrifugation, tangential flow, ion-exchange column chromatography, gel chromotpgraphy etc., manufacturing lentiviral products which meet the demand of various experiments such as immortalized cells, primary and stem cells or cGMP cell therapy.

(c)2018 GENECHEM All Rights Reserved.

BACK TOP